Belite Bio Inc

BLTE | NASDAQ

Price Alert Chart Builder DCF Calculator

$174.91

+$1.51 (+0.87%)

Sep 22, 2026, 2:16 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-77.61M	-36.14M	-31.63M	-12.65M	-9.67M	-5.75M
Depreciation & Amortization	464K	449K	399K	198K	30K	17K
Stock-Based Compensation	38.92M	8.99M	3.82M	1.48M	1.53M	1.36M
Other Working Capital	2.62M	1.06M	-2.36M	-459K	640K	-73K
Other Non-Cash Items	-1.31M	-3.66M	4.69M	1.91M	-8K	1.39M
Deferred Income Tax	n/a	n/a	-4.69M	-1.91M	n/a	-1.39M
Change in Working Capital	2.55M	1.13M	-2.43M	-491K	640K	-69K
Operating Cash Flow	-36.99M	-29.23M	-29.84M	-11.46M	-7.47M	-4.44M
Capital Expenditures	-178K	-151K	-63K	-394K	-74K	-20K
Cash Acquisitions	n/a	n/a	n/a	n/a	18K	n/a
Purchase of Investments	-451.99M	-188.27M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	147.07M	77.84M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-35K	n/a	n/a	n/a	n/a
Investing Cash Flow	-305.11M	-110.57M	-63K	-394K	-56K	-20K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-2.32M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	370.37M	41.36M	-1.23M	-1.03M	n/a	86K
Financial Cash Flow	663.23M	83.6M	75.96M	36.96M	-583K	28.06M
Net Cash Flow	321.26M	-56.48M	46.07M	24.75M	-8.27M	23.6M
Free Cash Flow	-37.17M	-29.39M	-29.9M	-11.85M	-7.55M	-4.46M
Adj. Free Cash Flow	-76.09M	-38.37M	-33.72M	-13.34M	-9.08M	-5.83M
Maintenance CapEx	-178K	-151K	-63K	-198K	-30K	-17K
Growth CapEx	n/a	n/a	n/a	-196K	-44K	-3K
Owner Earnings	-37.17M	-29.39M	-29.9M	-11.66M	-7.5M	-4.46M